All Insights Report A Cost-Effectiveness Analysis of Intrauterine Spacers Used to Prevent the Formation of Intrauterine Adhesions Following Endometrial Cavity Surgery
A Cost-Effectiveness Analysis of Intrauterine Spacers Used to Prevent the Formation of Intrauterine Adhesions Following Endometrial Cavity Surgery
This analysis evaluates the cost-effectiveness of using conforming spacers post-surgery to prevent intrauterine adhesions (IUAs) in the US healthcare system, focusing on associated costs and IUA event rates over three and a half years using a decision tree model.
![A Cost-Effectiveness Analysis of Intrauterine Spacers Used to Prevent the Formation of Intrauterine Adhesions Following Endometrial Cavity Surgery](https://insights.axtria.com/hubfs/A%20Cost-Effectiveness%20Analysis%20of%20Intrauterine%20Spacers.jpg)
Surgical procedures in the endometrial cavity can damage the basal layers of the endothelial linings, leading to intrauterine adhesions (IUAs), which cause pregnancy loss, infertility, and complications. Preventing IUAs is crucial, and conforming spacers are used post-surgery to prevent their formation.
This analysis estimates the cost-effectiveness of conforming spacers in the US healthcare system, focusing on IUA event rates and associated costs. A decision tree model compared outcomes for patients using spacers versus those who did not, from a US payer perspective over three and a half years. Only direct healthcare costs were considered. The findings aim to help healthcare payers and providers decide on reimbursement for conforming spacers and evaluate their clinical benefits.
This report is a poster presentation of Axtria from ISPOR 2024.
Contact us at connect@axtria.com with any questions.
Complete the brief form to download the white paper
Recommended insights
![A Cost-Effectiveness Analysis of Intrauterine Spacers](https://insights.axtria.com/hubfs/Findings%20From%202020%E2%80%932023.jpg)
Report
Novel Drug Approvals by the U.S. Food and Drug Administration in Rare Diseases: Findings From 2020–2023
![A Cost-Effectiveness Analysis of Intrauterine Spacers](https://insights.axtria.com/hubfs/FDA-Approved%20Artificial%20Intelligence%20and%20Machine%20Learning-Enabled%20Medical%20Devices.jpg)
Report